Location
France, Europe
Cheque size
$1.5M - $45M
Investment Stage
Seed
Series A
Focus Areas
SaaS
BioTech
FinTech
Hardware
Insurance
Medical Devices
About Investor
Alain Chevallier is a senior partner in the BioMedTech team at Truffle Capital. Truffle Capital focuses on life sciences, medtech, biotech, fintech, and insurtech, invests at Seed and Series A, and lists a first ticket size of €1,000,000 - €35,000,000. He spent 30 years at Sanofi and its predecessor companies, including country leadership roles in Latin America and Japan and finance leadership roles as CFO of Aventis Pharma SA and Sanofi Aventis France. At Truffle, he co-founded Splicos, now Abivax, and helped lead the IPOs of Deinove, Abivax, and Carbios.
Similar Investors
CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,JB
Joe Bond
United Kingdom, Europe
$500K - $2M
Seed
,ER
Elliot Richmond
United Kingdom, Europe
$1M - $5M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.